These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 12788802)

  • 1. Androgens and cardiovascular disease.
    Liu PY; Death AK; Handelsman DJ
    Endocr Rev; 2003 Jun; 24(3):313-40. PubMed ID: 12788802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen therapy and atherosclerotic cardiovascular disease.
    McGrath KC; McRobb LS; Heather AK
    Vasc Health Risk Manag; 2008; 4(1):11-21. PubMed ID: 18629352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular disease and androgens: a review.
    Kaushik M; Sontineni SP; Hunter C
    Int J Cardiol; 2010 Jun; 142(1):8-14. PubMed ID: 19923015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is atherosclerotic cardiovascular disease an endocrinological disorder? The estrogen-androgen paradox.
    Phillips GB
    J Clin Endocrinol Metab; 2005 May; 90(5):2708-11. PubMed ID: 15687329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgens and cardiovascular disease: gender-related differences.
    Spoletini I; Caprio M; Vitale C; Rosano GM
    Menopause Int; 2013 Jun; 19(2):82-6. PubMed ID: 23761317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgens and cardiovascular disease.
    Yeap BB
    Curr Opin Endocrinol Diabetes Obes; 2010 Jun; 17(3):269-76. PubMed ID: 20186051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New perspectives on Mars and Venus: unravelling the role of androgens in gender differences in cardiovascular biology and disease.
    Ng MK
    Heart Lung Circ; 2007 Jun; 16(3):185-92. PubMed ID: 17448726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dark side of testosterone deficiency: III. Cardiovascular disease.
    Traish AM; Saad F; Feeley RJ; Guay A
    J Androl; 2009; 30(5):477-94. PubMed ID: 19342698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular effect of testosterone replacement therapy in aging male.
    Francomano D; Bruzziches R; Natali M; Aversa A; Spera G
    Acta Biomed; 2010; 81 Suppl 1():101-6. PubMed ID: 20518199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of estrogen/androgen regimens.
    Simon JA
    J Reprod Med; 2001 Mar; 46(3 Suppl):281-90. PubMed ID: 11304876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of androgens on the cardiovascular system.
    Rosano GM; Cornoldi A; Fini M
    J Endocrinol Invest; 2005; 28(3 Suppl):32-8. PubMed ID: 16042358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled trials - mechanistic studies of testosterone and the cardiovascular system.
    Jones TH; Kelly DM
    Asian J Androl; 2018; 20(2):120-130. PubMed ID: 29442075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal effects on blood vessels.
    Akishita M; Yu J
    Hypertens Res; 2012 Apr; 35(4):363-9. PubMed ID: 22297478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative impact of androgen and estrogen receptor activation in the effects of androgens on trabecular and cortical bone in growing male mice: a study in the androgen receptor knockout mouse model.
    Venken K; De Gendt K; Boonen S; Ophoff J; Bouillon R; Swinnen JV; Verhoeven G; Vanderschueren D
    J Bone Miner Res; 2006 Apr; 21(4):576-85. PubMed ID: 16598378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy and safety of hormonal therapy with androgens (androgel) in men with erectile dysfunction, partial androgen deficiency of aging male and cardiovascular diseases].
    Kalinchenko SIu; Vorslov LO; Aglamazian NL; Morgunov LIu
    Urologiia; 2007; (1):57, 59-61. PubMed ID: 17472002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen metabolite-dependent growth of hormone receptor-positive breast cancer as a possible aromatase inhibitor-resistance mechanism.
    Hanamura T; Niwa T; Nishikawa S; Konno H; Gohno T; Tazawa C; Kobayashi Y; Kurosumi M; Takei H; Yamaguchi Y; Ito K; Hayashi S
    Breast Cancer Res Treat; 2013 Jun; 139(3):731-40. PubMed ID: 23780684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender differences in the cardiovascular effects of sex hormones.
    Vitale C; Fini M; Speziale G; Chierchia S
    Fundam Clin Pharmacol; 2010 Dec; 24(6):675-85. PubMed ID: 20199585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen-induced progression of arterial calcification in apolipoprotein E-null mice is uncoupled from plaque growth and lipid levels.
    McRobb L; Handelsman DJ; Heather AK
    Endocrinology; 2009 Feb; 150(2):841-8. PubMed ID: 19176322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal supplementation and erectile dysfunction.
    Aversa A; Isidori AM; Greco EA; Giannetta E; Gianfrilli D; Spera E; Fabbri A
    Eur Urol; 2004 May; 45(5):535-8. PubMed ID: 15082192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgens and bone.
    Vanderschueren D; Vandenput L; Boonen S; Lindberg MK; Bouillon R; Ohlsson C
    Endocr Rev; 2004 Jun; 25(3):389-425. PubMed ID: 15180950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.